Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles with high enantioselectivity for anticancer drug development and pharmaceutical intermediates.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Novel metal-free synthesis for trifluoromethyl selenium azaspiro compounds. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN118126005B reveals metal-free synthesis for fluorinated heterocycles. Delivers high purity, cost efficiency, and scalable supply chain solutions for global pharmaceutical manufacturing.
Novel nickel-catalyzed carbonylation method for indole synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates significantly.
Patent CN113105357B reveals a metal-free synthesis route for high-purity azophenol derivatives, offering cost reduction and scalable manufacturing for global supply chains.
Novel Pd-catalyzed bis-carbonylation method offers high yields and scalability for bioactive furanone production, significantly reducing manufacturing costs.
Novel metal-free synthesis method offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally for clients.
Patent CN109053603A enables aqueous synthesis of triazoles. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN113735778B reveals efficient Ag2O promoted route. Delivers high purity imidazole intermediates with substantial cost reduction and supply chain reliability.
Patent CN117164534A reveals a novel Pd-catalyzed carbonylation route for benzofuran derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115785122A details a novel Sc(OTf)3-catalyzed synthesis of indole-derived piperidines with high cytotoxicity, offering a scalable route for reliable pharmaceutical intermediate suppliers.
Novel reductive aminocarbonylation route using nitroarenes offers high yields and broad substrate tolerance for complex pharmaceutical intermediate manufacturing.
Novel synthesis of Danshensu Isopropyl Ester via Darzens epoxidation ensures high purity and yield. Reliable supply chain partner for cardiovascular drug intermediates.
Patent CN114751883B reveals a novel Pd-catalyzed carbonylation route for benzofuran-3-carboxamide, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel palladium-catalyzed carbonylation method for quinoline-4(1H)-one. Enhances purity, reduces cost, ensures supply chain reliability for pharmaceutical intermediates.
Patent CN111423381B reveals a mild Pd-catalyzed route for 2-trifluoromethyl imidazoles, offering cost-effective API intermediate manufacturing with high substrate tolerance.
Patent CN114920707B reveals a novel DMF-based synthesis for 3-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production capabilities.
Patent CN107698590B details a novel asymmetric [3+2] cyclization for chiral carbocyclic purine nucleosides, offering high yields and enantioselectivity for reliable pharmaceutical intermediate supply.
Patent CN110002952A reveals iridium-catalyzed transfer hydrogenation for high-purity alcohol synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.